home About Us People Portfolio Contact Us Fund II Investor Login » Fund III Investor Login » Fund IV Investor Login » Fund V Investor Log In »

Cognate Bioservices


Pharmaceutical Services

In April 2021, Charles River acquired Cognate BioServices, the premier contract development and manufacturing organization for cell and gene-mediated cell therapy.